Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Name: Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al
Creator: Julia Vanlerberghe
Published: 2022-05-09T12:59:27.751Z
Keywords: Descriptive Table

Vanlerberghe, Julia

doi:10.17632/5jy3c6jrrr.1

Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Published: 9 May 2022| Version 1 | DOI: 10.17632/5jy3c6jrrr.1

Contributor:

Julia Vanlerberghe

Description

Supplementary table II : number and reasons of JAK inhibitor discontinuation

Files

Institutions

Universite de Lille

Supplementeray table II- Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort. Vanlerberghe et al

Description

Files

Institutions

Categories

Licence